Ipca Laboratories Ltd.
ShareIPCALAB Share price chart
*Stock prices shown are delayed by 5 minutes
Key Indicators
Data as per latest reports and statements
| Today's low/high | ₹1,426.90 / ₹1,455.00 |
| 52-week low/high | ₹1,168.20 / ₹1,755.90 |
| Circuit range | ₹1,153.76 / ₹1,730.64 |
| Market cap | ₹36,589 Cr |
| PE ratio (TTM) | 49.60 |
| Sector PE | 40.45 |
| ROE | 11.86% |
| ROCE | 17.80% |
| Basic EPS (TTM) | ₹29.08 |
| Diluted EPS | ₹29.08 |
| Book Value per share | ₹273.88 |
| Face Value per share | ₹1 |
| PB ratio | 5.27 |
| Debt to equity | 0.19 |
| Dividend Yield | 0.28% |
| EBITDA Margin (TTM) | 19.79% |
Returns calculator
- Total investment₹10,000
- Loss- ₹963
- Dividends+ ₹28
- Total corpus₹9,065
- Absolute returns-9.35%
Financials
FY 25- Metric
- Value
- YoY growth
- Operating Revenue
₹8,940 Cr
- EBITDA
₹1,819 Cr
- Profit Before Tax
₹1,131 Cr
- Profit After Tax
₹787.53 Cr
About Ipca Laboratories Ltd.
Business Verticals & Subsidiaries
- Ramdev Chemical Pvt.Ltd.
- Unichem Laboratories Ltd.
- Niche Generics Ltd.
- Unichem S.A (Proprietary ) Ltd.
- IPCA Pharmaceuticals Inc., USA
Ipca Laboratories Ltd. Stock Market Performance
- Nifty Midcap 150
- Nifty 500
- Nifty LargeMidcap 250
- Nifty Pharma
- S&P BSE Healthcare
The Latest Details of IPCALAB Earnings
The Latest Updates on IPCALAB Share Price
Ipca Laboratories Ltd.'s Board of Directors
| Name | Position |
|---|---|
| Mr. Premchand Godha | Executive Chairman |
| Mr. Ajit Kumar Jain | Managing Director & CFO |
| Mr. Pranay Godha | Managing Director & CEO |
IPCALAB Shares FAQs
Ipca Laboratories Ltd.'s total assets as of 31 Mar 2025 stood at Rs.11,761 Cr.
Ipca Laboratories Ltd.'s share price as of 21 Nov 2025 is Rs.1,442.20. Over the past 1 month, Ipca Laboratories Ltd.'s share price has increased by 11.95%.
The market cap of Ipca Laboratories Ltd. stood at Rs.36,589 Cr as of 21 Nov 2025.
Kaygee Investments Private Limited:Holds a stake of 21.47%
Kaygee Laboratories Private Limited:Holds a stake of 6.61%
Chandurkar Investments Private Limited:Holds a stake of 5.5%
The PE ratio of Ipca Laboratories Ltd. is 49.6, and the PB ratio is 5.27.
Ipca Laboratories Ltd. was established in 1949.
To analyze Ipca Laboratories Ltd. stock, start by researching the company's financial health, including its revenue, profit margins, debt levels, and cash flow. Look into industry trends, competition, and any recent news or developments that might impact Ipca Laboratories Ltd..
The 52-week low for Ipca Laboratories Ltd.'s share price was Rs.1,168.20 and the 52-week high was Rs.1,755.90.
21 Nov 2025 Stock Performance for Ipca Laboratories Ltd.
On Friday, 21 Nov 2025, Ipca Laboratories Ltd.'s stocks opened at Rs.1,427 and closed at Rs.1,442.20. The day's trading saw the stock reach a high of Rs.1,455 and a low of Rs.1,426.90.
Ipca Laboratories Ltd. is listed on NSE. It is also listed on BSE.
